Cipla is a leading player in anti-infective and anti-asthmatic formulations. The company also specializes in the manufacturing of steroids and hormones. Cipla's R&D division focuses on the development of new products and new drug delivery systems across a range of therapies. The company is spending over 4 per cent of its total turnover on R&D activities.

Core Sales Territory: All of Europe

Core Operation: API Manufacture, Finished Dose Manufacture, Sales and Marketing, Distribution

Number of molecules sold: > 400

Company's rating: